SCHEMBL4520325

SCHEMBL4520325

CCNC(=O)c1[nH]c2ccc(O)cc2c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
GAA P10253 5/20 0.49
KDM4E B2RXH2 5/20 0.49
MAPT P10636 5/20 0.49
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CNR1 P21554 3/20 0.47
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
RAB9A P51151 2/20 0.45
HPGD P15428 2/20 0.45
NPC1 O15118 1/20 0.45
EGFR P00533 1/20 0.43
CDK2 P24941 1/20 0.43
LMNA P02545 2/20 0.43
SPR P35270 1/20 0.43
THRB P10828 1/20 0.43
NR1I2 O75469 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3993254 0.89 CNR1 (0.51) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL3993256 0.80 EGFR (0.46) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL5962663 0.80 ALDH1A1 (0.60) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL3985463 0.78 KDM4E (0.71) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL3986203 0.78 ALDH1A1 (0.55) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL3988373 0.77 KDM4E (0.68) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL20794394 0.76 CNR1 (0.42) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL20769926 0.75 BRD4 (0.55) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL3990672 0.75 KDM4E (0.58) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL8146075 0.73 GABRA1 (0.67) MEN1KMT2AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
EP-2035377-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2009-03-18 EP disclosed
WO-2007134864-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands TSHR, TRHR, THRA MEN1 855/4885KMT2A 1408/4885GAA 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.